Description

Description

Galvecta 50mg is a prescription-based oral medication manufactured by PharmaEvo, containing Vildagliptin as its active ingredient. Each pack contains 10 tablets formulated to support the management of type 2 diabetes mellitus in adults. Vildagliptin belongs to a class of medicines known as DPP-4 inhibitors (dipeptidyl peptidase-4 inhibitors), which work by increasing the levels of certain natural hormones in the body that help regulate blood sugar, prompting the pancreas to release more insulin when blood sugar is high and reducing the amount of glucose produced by the liver. This mechanism offers a relatively gentle approach to blood sugar management, with a lower likelihood of causing significant drops in blood sugar compared to some other diabetes medication classes. Galvecta is often prescribed either as a standalone therapy or in combination with other antidiabetic medications, depending on a physician’s assessment of individual treatment needs. It is intended to be used alongside lifestyle measures such as a balanced diet, regular physical activity, and routine blood sugar monitoring, and is not a substitute for insulin in patients who require it.

Ingredients

The primary active ingredient in Galvecta 50mg tablets is Vildagliptin, present in a strength of 50mg per tablet. The formulation also includes standard pharmaceutical excipients such as binders, fillers, and coating agents, which support tablet stability, appearance, and ease of administration. These inactive components do not contribute to the therapeutic action of the medicine but are necessary for proper tablet formation and consistent quality.

Dosage Form

Galvecta is available in the form of oral tablets, each containing 50mg of Vildagliptin. The pack includes 10 tablets, offering a supply typically aligned with short-term prescription cycles or as directed by a treating physician.

Uses

Galvecta 50mg is primarily used to help improve blood sugar control in adults with type 2 diabetes mellitus. It may be prescribed alone or in combination with other antidiabetic medicines such as Metformin, sulfonylureas, or insulin, depending on individual patient needs and treatment goals as determined by a physician. It is generally used as part of a broader diabetes management plan and is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.

How to Use

Galvecta tablets are typically taken once or twice daily, with or without food, as directed by a doctor, depending on whether it is prescribed alone or in combination with other diabetes medicines. The tablet should be swallowed whole with a glass of water and should not be crushed or chewed unless specifically instructed. Dosage and duration of treatment should strictly follow the prescribing physician’s instructions, as individual requirements may vary based on liver function, other medications being taken, and overall blood sugar control. If a dose is missed, it should be taken as soon as remembered unless it is close to the time of the next dose, in which case the missed dose should be skipped rather than doubled.

Side Effects

As with most medications, Galvecta may cause side effects in some individuals, though not everyone experiences them. Commonly reported effects include dizziness, headache, and mild gastrointestinal discomfort such as nausea. When used in combination with other diabetes medicines, particularly sulfonylureas, there may be a slightly increased risk of low blood sugar. Less commonly, some patients may experience joint pain or changes in liver function. In rare cases, more serious effects such as severe allergic reactions, significant liver problems, or pancreatitis have been reported, and immediate medical attention should be sought if symptoms such as severe abdominal pain, persistent nausea, yellowing of the skin or eyes, or unusual fatigue occur.

Pregnancy & Breastfeeding

Galvecta is generally not recommended for use during pregnancy, as the safety of Vildagliptin in pregnant women has not been well established, and insulin is typically preferred for blood sugar management during this period. Women who are pregnant, planning pregnancy, or suspect they may be pregnant should inform their doctor immediately so that alternative treatment can be considered. Similarly, it is not advised for use during breastfeeding, as it is not fully established whether the medication passes into breast milk and what effects it may have on a nursing infant. Alternative treatment options are typically considered for diabetic patients during these periods, and any changes to medication should only be made under medical guidance.

Storage Instructions

Galvecta tablets should be stored in a cool, dry place away from direct sunlight and moisture, ideally at room temperature. Keep the medicine in its original packaging until the time of use, and ensure it is stored out of reach of children and pets. Do not use the tablets beyond the expiry date printed on the pack, and dispose of any unused or expired medication safely according to local pharmaceutical disposal guidelines.

FAQs

Does Galvecta cause low blood sugar on its own?
When used alone, Galvecta has a relatively low risk of causing hypoglycemia, though this risk may increase when it is combined with other diabetes medicines such as sulfonylureas or insulin.

Can Galvecta be taken with other diabetes medicines?
Yes, it is often prescribed alongside other antidiabetic medications, but only under medical supervision to monitor for effectiveness and any interaction-related risks.

Is Galvecta suitable for patients with liver problems?
Vildagliptin requires adequate liver function for safe use, so patients with existing liver conditions should be carefully evaluated by their doctor before starting this medicine.

How long does it take to see results with Galvecta?
Blood sugar improvement is generally gradual, and your doctor will monitor your response over the following weeks to assess whether further dose adjustment is needed.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.